Top Markets
#1 CyberDEX CyberDEX +678.12%
#2 龙虾 (Lobster) 龙虾 (Lobster) +27.21%
#3 GEKKO GEKKO +23.15%
#4 Harmony Harmony +21.88%
#5 PumpMeme PumpMeme +18.57%
#6 Stargate Finance Stargate Finance +18.34%
#7 LayerZero LayerZero +18.29%
#8 Starknet Starknet +17.27%
#9 Zama Zama +16.13%
#10 DexNet DexNet +15.52%
Coin of the day
CyberDEX CyberDEX
Settings
Language
ENGLISH
Currency
USD
Theme
Aoxing Pharmaceutical Company, Inc. Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc.

AOXG
Rank in Stocks #38632
Aoxing Pharmaceutical Company, Inc. is a specialized drug manufacturer... Aoxing Pharmaceutical Company, Inc. is a specialized drug manufacturer primarily operating within the People's Republic of China. The company dedicates itself to the research, development, production, and distribution of pharmaceutical products, with a strong emphasis on narcotics, pain management solutions, and addiction treatments. Its current product portfolio includes Zhongtong'an, a capsule derived from herbal extracts used for relieving oral and dental discomfort; Yiqi Qiangshen Granule, an over-the-counter herbal preparation designed to invigorate qi, strengthen the body, and improve blood flow by clearing meridian blockages; and Tilidine hydrochloride. The latter is an oral synthetic narcotic analgesic tablet, available in 50mg or 100mg doses, prescribed for the alleviation of acute, moderate to severe pain, as well as chronic pain associated with cancer. Aoxing also boasts several promising products in its development pipeline. These include Oxycodone and Acetaminophen tablets and capsules, which have successfully completed clinical trials for both acute and chronic pain management. Another is Buprenorphine/Naloxone, a sublingual combination tablet that has finished Phase II clinical trials as a treatment for opioid dependence. Furthermore, a Tilidine/Naloxone compound capsule is currently undergoing Phase II clinical trials, targeting acute and chronic pain. Initially known as China Aoxing Pharmaceutical Company, Inc., the firm rebranded to Aoxing Pharmaceutical Company, Inc. in March 2010. Its corporate headquarters are situated in Shijiazhuang, China.
Share Price
$0.0022
Last synced: 2026-10-02
Market Cap
$838.66K
Change (1 day)
0.00%
Change (1 year)
-77.55%
Country
US
Trade Aoxing Pharmaceutical Company, Inc. (AOXG)

Category

Healthcare
Revenue for Aoxing Pharmaceutical Company, Inc. (AOXG)
Revenue in Oct 2026 TTM: 0
According to Aoxing Pharmaceutical Company, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Aoxing Pharmaceutical Company, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.88B -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT